The founding Advisory Board was established in March 2014. Advisory board members hold a leadership position in their organization and can provide knowledge, recommendations, objective advice and guidance from other academic institutions, industry and government in areas that are relevant to CBB and its members.
Members provide an ongoing exchange of information between industry and CBB, help promote CBB and communicate the Centre's activities to industry, government, the research community, the university and the public.
Members are nominated by the Operations Committee and are selected by the Centre Director. Members serve for an initial three year term that may be renewed.
Meetings are held 1-2 times annually and are open to the Director and Associate Directors of CBB, CBB Operations Committee and staff.
|
 Chair
Associate
Vice-President, |
Members:
 âMarch 2014-April 2019, renewed 2017 Director Product Development, Biopharmaceuticals, Apobiologix |
 April 2018-April 2021 Sr. Director of Finance & Operations, CFO, Medtronic Canada |
 March 2014-April 2019, renewed 2017 National Zone Leader, Life Science GE Healthcare Canada |
 April 2017-2020 President and CEO, Ontario Bioscience Innovation Organization OBIO) |
 âMarch 2014-April 2019, renewed 2017 VP and Chief Information Officer, St. Mary's Hospital |
 April 2018-2021 Scientific Co-Founder and CEO, Novoheart Limited; Director, Ming-Wai Lau Centre for Reparative Medicine, Karolinksa Institute, Hong Kong, Sweden |
 April 2018-2021 Vice President Research and Innovation, Grand River Hospital |
 âApril 2017-2020 CEO and Co-Founder, Finesse Solutions |